Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Treatment (HSV-1, HSV-2), By Drug, By Vaccine, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 4 Business Days
Herpes Simplex Virus Treatment Market Growth & Trends
The global herpes simplex virus treatment market size is expected to reach USD 3.75 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.81% from 2022 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.
According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.
Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.
Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth.
Herpes Simplex Virus Treatment Market Report Highlights
Herpes Simplex Virus Treatment Market Growth & Trends
The global herpes simplex virus treatment market size is expected to reach USD 3.75 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.81% from 2022 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.
According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.
Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.
Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth.
Herpes Simplex Virus Treatment Market Report Highlights
- By treatment, the HSV-1 segment held the largest share in 2021 owing to the high prevalence of infection
- By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
- By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
- North America dominated the global market in 2021 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure
CHAPTER 1 HERPES SIMPLEX VIRUS TREATMENT MARKET: METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (model 2)
1.6.2.1 Approach 2: Volume price analysis
1.6.2.2 Revenue modeling
1.7 List of Secondary Sources
1.8 List of Primary Sources
CHAPTER 2 HERPES SIMPLEX VIRUS TREATMENT MARKET: EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 HERPES SIMPLEX VIRUS TREATMENT MARKET: INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing prevalence of herpes infection
3.3.1.2 Development of novel treatment options
3.3.1.3 Increasing government funding
3.3.1.3 Technological advancements
3.3.2 Market Restraint Analysis
3.3.2.1 Unavailability of vaccine
3.4 Porter’s Five Forces Analysis
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Regulatory Framework
3.7 User Perspective Analysis
CHAPTER 4 HERPES SIMPLEX VIRUS TREATMENT MARKET: COMPETITIVE LANDSCAPE
4.1 Recent developments & impact analysis, by key market participants
4.1.1 Ansoff Matrix
4.2 Major deals & strategic alliances analysis
4.2.1 Joint Ventures
4.2.2 Licensing and Partnerships
4.2.3 Technological Collaborations
4.3 Company/Competition Categorization
4.4 Vendor Landscape
4.4.1 List Of Key Distributors and Channel Partners
4.4.2 Key Customers
4.5 Public Companies
4.5.1 Company Market Position Analysis
4.6 Private Companies
4.6.1 List Of Key Emerging Companies
4.6.2 Regional Network Map
CHAPTER 5 HERPES SIMPLEX VIRUS TREATMENT MARKET: TREATMENT BUSINESS ANALYSIS
5.1 Definition and Scope
5.2 Treatment Market Share Analysis, 2021 & 2030
5.3 Global Herpes Simplex Virus Treatment Market, By Treatment, 2018 To 2030
5.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1 Herpes Simplex Virus-1 (HSV-1)
5.4.1.1 Herpes Simplex Virus-1 (HSV-1) Market 2018 - 2030 (USD Million)
5.4.2 Herpes Simplex Virus-2 (HSV-2)
5.4.2.1 Herpes Simplex Virus-2 (HSV-2) Market, 2018 - 2030 (USD Million)
CHAPTER 6 HERPES SIMPLEX VIRUS TREATMENT MARKET: DRUG BUSINESS ANALYSIS
6.1 Definition and Scope
6.2 Drug Market Share Analysis, 2021 & 2030
6.3 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 To 2030
6.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4.1 Acyclovir
6.4.1.1 Acyclovir Market 2018 - 2030 (USD Million)
6.4.2 Valacyclovir
6.4.2.1 Valacyclovir Market, 2018 - 2030 (USD Million)
6.4.3 Famciclovir
6.4.3.1 Famciclovir Market, 2018 - 2030 (USD Million)
6.4.4 Other Drugs
6.4.4.1 Other Drugs Market, 2018 - 2030 (USD Million)
CHAPTER 7 HERPES SIMPLEX VIRUS TREATMENT MARKET: VACCINE BUSINESS ANALYSIS
7.1 Definition and Scope
7.2 Vaccine Market Share Analysis, 2021 & 2030
7.3 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 To 2030
7.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.4.1 Simplirix
7.4.1.1 Drug Discovery and Development Market 2018 - 2030 (USD Million)
7.4.4 Others
7.4.4.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 8 HERPES SIMPLEX VIRUS TREATMENT MARKET: ROUTE OF ADMINISTRATION BUSINESS ANALYSIS
8.1 Definition and Scope
8.2 Route of Administration Market Share Analysis, 2021 & 2030
8.3 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 To 2030
8.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.4.1 Oral
8.4.1.1 Oral Market 2018 - 2030 (USD Million)
8.4.2 Injectable
8.4.2.1 Injectable Market, 2018 - 2030 (USD Million)
8.4.3 Topical
8.4.3.1 Topical Market, 2018 - 2030 (USD Million)
CHAPTER 9 HERPES SIMPLEX VIRUS TREATMENT MARKET: END-USE BUSINESS ANALYSIS
9.1 Definition and Scope
9.2 End-use Market Share Analysis, 2021 & 2030
9.3 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 To 2030
9.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
9.4.1 Drug Discovery and Development
9.4.1.1 Drug Discovery and Development Market 2018 - 2030 (USD Million)
9.4.2 Hospital Pharmacy
9.4.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
9.4.3 Retail Pharmacy
9.4.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
9.4.4 Online Pharmacy
9.4.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
CHAPTER 10 HERPES SIMPLEX VIRUS TREATMENT MARKET: REGIONAL BUSINESS ANALYSIS
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
10.7 North America
10.7.1 North America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.7.2 U.S.
10.7.2.1 U.S. Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.7.3 Canada
10.7.3.1 Canada Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8 Europe
10.8.1 Europe Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.2 U.K.
10.8.2.1 U.K. Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.3 Germany
10.8.3.1 Germany Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.4 France
10.8.4.1 France Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.5 Italy
10.8.5.1 Italy Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.6 Spain
10.8.6.1 Spain Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9 Asia Pacific
10.9.1 Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.2 Japan
10.9.2.1 Japan Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.3 China
10.9.3.1 China Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.4 India
10.9.4.1 India Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.5 Australia
10.9.5.1 Australia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.6 South Korea
10.9.6.1 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10 Latin America
10.10.1 Latin America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10.2 Brazil
10.10.2.1 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10.3 Mexico
10.10.3.1 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10.4 Argentina
10.10.4.1 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11 MEA
10.11.1 MEA Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11.2 South Africa
10.11.2.1 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11.4 UAE
10.11.4.1 UAE Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
CHAPTER 11 HERPES SIMPLEX VIRUS TREATMENT MARKET: COMPANY PROFILING
11.1 Company Profiles
11.1.1 GSK plc
11.1.1.1 Company Overview
11.1.1.2 Financial Performance
11.1.1.3 Product Benchmarking
11.1.1.4 Strategic Initiatives
11.1.2 Carlsbad Tech
11.1.2.1 Company Overview
11.1.2.2 Financial Performance
11.1.2.3 Product Benchmarking
11.1.2.4 Strategic Initiatives
11.1.3 Emcure Pharmaceuticals Ltd.
11.1.3.1 Company Overview
11.1.3.2 Financial Performance
11.1.3.3 Product Benchmarking
11.1.3.4 Strategic Initiatives
11.1.4 Novartis AG
11.1.4.1 Company Overview
11.1.4.2 Financial Performance
11.1.4.3 Product Benchmarking
11.1.4.4 Strategic Initiatives
11.1.5 Glenmark Pharmaceuticals Inc.
11.1.5.1 Company Overview
11.1.5.2 Financial Performance
11.1.5.3 Product Benchmarking
11.1.5.4 Strategic Initiatives
11.1.6 Fresenius Kabi AG
11.1.6.1 Company Overview
11.1.6.2 Financial Performance
11.1.6.3 Product Benchmarking
11.1.6.4 Strategic Initiatives
11.1.7 Apotex Inc.
11.1.7.1 Company Overview
11.1.7.2 Financial Performance
11.1.7.3 Product Benchmarking
11.1.7.4 Strategic Initiatives
11.1.8 Viatris Inc.
11.1.8.1 Company Overview
11.1.8.2 Financial Performance
11.1.8.3 Product Benchmarking
11.1.8.4 Strategic Initiatives
11.1.9 Teva Pharmaceuticals Industries Ltd.
11.1.9.1Company Overview
11.1.9.2 Financial Performance
11.1.9.3 Product Benchmarking
11.1.9.4 Strategic Initiatives
11.1.10 Sanofi
11.1.10.1 Company Overview
11.1.10.2 Financial Performance
11.1.10.3 Product Benchmarking
11.1.10.4 Strategic Initiatives
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (model 2)
1.6.2.1 Approach 2: Volume price analysis
1.6.2.2 Revenue modeling
1.7 List of Secondary Sources
1.8 List of Primary Sources
CHAPTER 2 HERPES SIMPLEX VIRUS TREATMENT MARKET: EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 HERPES SIMPLEX VIRUS TREATMENT MARKET: INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing prevalence of herpes infection
3.3.1.2 Development of novel treatment options
3.3.1.3 Increasing government funding
3.3.1.3 Technological advancements
3.3.2 Market Restraint Analysis
3.3.2.1 Unavailability of vaccine
3.4 Porter’s Five Forces Analysis
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Regulatory Framework
3.7 User Perspective Analysis
CHAPTER 4 HERPES SIMPLEX VIRUS TREATMENT MARKET: COMPETITIVE LANDSCAPE
4.1 Recent developments & impact analysis, by key market participants
4.1.1 Ansoff Matrix
4.2 Major deals & strategic alliances analysis
4.2.1 Joint Ventures
4.2.2 Licensing and Partnerships
4.2.3 Technological Collaborations
4.3 Company/Competition Categorization
4.4 Vendor Landscape
4.4.1 List Of Key Distributors and Channel Partners
4.4.2 Key Customers
4.5 Public Companies
4.5.1 Company Market Position Analysis
4.6 Private Companies
4.6.1 List Of Key Emerging Companies
4.6.2 Regional Network Map
CHAPTER 5 HERPES SIMPLEX VIRUS TREATMENT MARKET: TREATMENT BUSINESS ANALYSIS
5.1 Definition and Scope
5.2 Treatment Market Share Analysis, 2021 & 2030
5.3 Global Herpes Simplex Virus Treatment Market, By Treatment, 2018 To 2030
5.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1 Herpes Simplex Virus-1 (HSV-1)
5.4.1.1 Herpes Simplex Virus-1 (HSV-1) Market 2018 - 2030 (USD Million)
5.4.2 Herpes Simplex Virus-2 (HSV-2)
5.4.2.1 Herpes Simplex Virus-2 (HSV-2) Market, 2018 - 2030 (USD Million)
CHAPTER 6 HERPES SIMPLEX VIRUS TREATMENT MARKET: DRUG BUSINESS ANALYSIS
6.1 Definition and Scope
6.2 Drug Market Share Analysis, 2021 & 2030
6.3 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 To 2030
6.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4.1 Acyclovir
6.4.1.1 Acyclovir Market 2018 - 2030 (USD Million)
6.4.2 Valacyclovir
6.4.2.1 Valacyclovir Market, 2018 - 2030 (USD Million)
6.4.3 Famciclovir
6.4.3.1 Famciclovir Market, 2018 - 2030 (USD Million)
6.4.4 Other Drugs
6.4.4.1 Other Drugs Market, 2018 - 2030 (USD Million)
CHAPTER 7 HERPES SIMPLEX VIRUS TREATMENT MARKET: VACCINE BUSINESS ANALYSIS
7.1 Definition and Scope
7.2 Vaccine Market Share Analysis, 2021 & 2030
7.3 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 To 2030
7.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.4.1 Simplirix
7.4.1.1 Drug Discovery and Development Market 2018 - 2030 (USD Million)
7.4.4 Others
7.4.4.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 8 HERPES SIMPLEX VIRUS TREATMENT MARKET: ROUTE OF ADMINISTRATION BUSINESS ANALYSIS
8.1 Definition and Scope
8.2 Route of Administration Market Share Analysis, 2021 & 2030
8.3 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 To 2030
8.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.4.1 Oral
8.4.1.1 Oral Market 2018 - 2030 (USD Million)
8.4.2 Injectable
8.4.2.1 Injectable Market, 2018 - 2030 (USD Million)
8.4.3 Topical
8.4.3.1 Topical Market, 2018 - 2030 (USD Million)
CHAPTER 9 HERPES SIMPLEX VIRUS TREATMENT MARKET: END-USE BUSINESS ANALYSIS
9.1 Definition and Scope
9.2 End-use Market Share Analysis, 2021 & 2030
9.3 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 To 2030
9.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
9.4.1 Drug Discovery and Development
9.4.1.1 Drug Discovery and Development Market 2018 - 2030 (USD Million)
9.4.2 Hospital Pharmacy
9.4.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
9.4.3 Retail Pharmacy
9.4.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
9.4.4 Online Pharmacy
9.4.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
CHAPTER 10 HERPES SIMPLEX VIRUS TREATMENT MARKET: REGIONAL BUSINESS ANALYSIS
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
10.7 North America
10.7.1 North America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.7.2 U.S.
10.7.2.1 U.S. Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.7.3 Canada
10.7.3.1 Canada Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8 Europe
10.8.1 Europe Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.2 U.K.
10.8.2.1 U.K. Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.3 Germany
10.8.3.1 Germany Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.4 France
10.8.4.1 France Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.5 Italy
10.8.5.1 Italy Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.8.6 Spain
10.8.6.1 Spain Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9 Asia Pacific
10.9.1 Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.2 Japan
10.9.2.1 Japan Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.3 China
10.9.3.1 China Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.4 India
10.9.4.1 India Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.5 Australia
10.9.5.1 Australia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.9.6 South Korea
10.9.6.1 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10 Latin America
10.10.1 Latin America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10.2 Brazil
10.10.2.1 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10.3 Mexico
10.10.3.1 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.10.4 Argentina
10.10.4.1 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11 MEA
10.11.1 MEA Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11.2 South Africa
10.11.2.1 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
10.11.4 UAE
10.11.4.1 UAE Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
CHAPTER 11 HERPES SIMPLEX VIRUS TREATMENT MARKET: COMPANY PROFILING
11.1 Company Profiles
11.1.1 GSK plc
11.1.1.1 Company Overview
11.1.1.2 Financial Performance
11.1.1.3 Product Benchmarking
11.1.1.4 Strategic Initiatives
11.1.2 Carlsbad Tech
11.1.2.1 Company Overview
11.1.2.2 Financial Performance
11.1.2.3 Product Benchmarking
11.1.2.4 Strategic Initiatives
11.1.3 Emcure Pharmaceuticals Ltd.
11.1.3.1 Company Overview
11.1.3.2 Financial Performance
11.1.3.3 Product Benchmarking
11.1.3.4 Strategic Initiatives
11.1.4 Novartis AG
11.1.4.1 Company Overview
11.1.4.2 Financial Performance
11.1.4.3 Product Benchmarking
11.1.4.4 Strategic Initiatives
11.1.5 Glenmark Pharmaceuticals Inc.
11.1.5.1 Company Overview
11.1.5.2 Financial Performance
11.1.5.3 Product Benchmarking
11.1.5.4 Strategic Initiatives
11.1.6 Fresenius Kabi AG
11.1.6.1 Company Overview
11.1.6.2 Financial Performance
11.1.6.3 Product Benchmarking
11.1.6.4 Strategic Initiatives
11.1.7 Apotex Inc.
11.1.7.1 Company Overview
11.1.7.2 Financial Performance
11.1.7.3 Product Benchmarking
11.1.7.4 Strategic Initiatives
11.1.8 Viatris Inc.
11.1.8.1 Company Overview
11.1.8.2 Financial Performance
11.1.8.3 Product Benchmarking
11.1.8.4 Strategic Initiatives
11.1.9 Teva Pharmaceuticals Industries Ltd.
11.1.9.1Company Overview
11.1.9.2 Financial Performance
11.1.9.3 Product Benchmarking
11.1.9.4 Strategic Initiatives
11.1.10 Sanofi
11.1.10.1 Company Overview
11.1.10.2 Financial Performance
11.1.10.3 Product Benchmarking
11.1.10.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Herpes Simplex Virus Treatment Market, By Region, 2018 - 2030 (USD Million)
TABLE 5 Global Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 6 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 7 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 8 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 9 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 10 North America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 11 North America Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 12 North America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 13 North America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 14 North America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 15 North America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 16 U.S. Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 17 U.S. Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 18 U.S. Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 19 U.S. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 20 U.S. Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 21 Canada Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 22 Canada Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 23 Canada Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 24 Canada Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 25 Canada Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 26 Europe Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 27 Europe Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 28 Europe Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 29 Europe Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 30 Europe Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 31 Europe Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 32 U.K. Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 33 U.K. Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 34 U.K. Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 35 U.K. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 36 U.K. Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 37 Germany Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 38 Germany Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 39 Germany Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 40 Germany Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 41 Germany Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 42 France Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 43 France Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 44 France Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 45 France Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 46 France Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 47 Spain Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 48 Spain Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 49 Spain Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 50 Spain Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 51 Spain Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 52 Italy Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 53 Italy Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 54 Italy Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 55 Italy Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 56 Italy Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 57 Asia Pacific Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 58 Asia Pacific Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 59 Asia Pacific Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 60 Asia Pacific Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 61 Asia Pacific Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 62 Asia Pacific Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 63 China Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 64 China Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 65 China Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 66 China Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 67 China Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 68 Japan Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 69 Japan Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 70 Japan Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 71 Japan Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 72 Japan Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 73 India Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 74 India Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 75 India Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 76 India Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 77 India Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 78 South Korea Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 79 South Korea Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 80 South Korea Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 81 South Korea Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 82 South Korea Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 83 Australia Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 84 Australia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 85 Australia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 86 Australia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 87 Australia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 88 Latin America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 89 Latin America Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 90 Latin America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 91 Latin America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 92 Latin America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 93 Latin America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 94 Brazil Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 95 Brazil Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 96 Brazil Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 97 Brazil Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 98 Brazil Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 99 Mexico Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 100 Mexico Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 101 Mexico Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 102 Mexico Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 103 Mexico Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 104 Argentina Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 105 Argentina Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 106 Argentina Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 107 Argentina Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 108 Argentina Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 109 MEA Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 110 MEA Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 111 MEA Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 112 MEA Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 113 MEA Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 114 MEA Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 115 South Africa Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 116 South Africa Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 117 South Africa Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 118 South Africa Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 119 South Africa Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 120 Saudi Arabia Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 121 Saudi Arabia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 122 Saudi Arabia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 123 Saudi Arabia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 124 Saudi Arabia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 125 UAE Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 126 UAE Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 127 UAE Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 128 UAE Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 129 UAE Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Herpes Simplex Virus Treatment Market, By Region, 2018 - 2030 (USD Million)
TABLE 5 Global Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 6 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 7 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 8 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 9 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 10 North America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 11 North America Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 12 North America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 13 North America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 14 North America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 15 North America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 16 U.S. Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 17 U.S. Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 18 U.S. Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 19 U.S. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 20 U.S. Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 21 Canada Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 22 Canada Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 23 Canada Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 24 Canada Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 25 Canada Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 26 Europe Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 27 Europe Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 28 Europe Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 29 Europe Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 30 Europe Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 31 Europe Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 32 U.K. Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 33 U.K. Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 34 U.K. Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 35 U.K. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 36 U.K. Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 37 Germany Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 38 Germany Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 39 Germany Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 40 Germany Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 41 Germany Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 42 France Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 43 France Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 44 France Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 45 France Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 46 France Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 47 Spain Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 48 Spain Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 49 Spain Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 50 Spain Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 51 Spain Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 52 Italy Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 53 Italy Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 54 Italy Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 55 Italy Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 56 Italy Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 57 Asia Pacific Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 58 Asia Pacific Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 59 Asia Pacific Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 60 Asia Pacific Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 61 Asia Pacific Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 62 Asia Pacific Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 63 China Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 64 China Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 65 China Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 66 China Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 67 China Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 68 Japan Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 69 Japan Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 70 Japan Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 71 Japan Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 72 Japan Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 73 India Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 74 India Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 75 India Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 76 India Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 77 India Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 78 South Korea Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 79 South Korea Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 80 South Korea Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 81 South Korea Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 82 South Korea Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 83 Australia Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 84 Australia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 85 Australia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 86 Australia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 87 Australia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 88 Latin America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 89 Latin America Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 90 Latin America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 91 Latin America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 92 Latin America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 93 Latin America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 94 Brazil Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 95 Brazil Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 96 Brazil Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 97 Brazil Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 98 Brazil Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 99 Mexico Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 100 Mexico Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 101 Mexico Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 102 Mexico Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 103 Mexico Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 104 Argentina Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 105 Argentina Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 106 Argentina Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 107 Argentina Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 108 Argentina Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 109 MEA Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
TABLE 110 MEA Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 111 MEA Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 112 MEA Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 113 MEA Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 114 MEA Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 115 South Africa Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 116 South Africa Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 117 South Africa Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 118 South Africa Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 119 South Africa Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 120 Saudi Arabia Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 121 Saudi Arabia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 122 Saudi Arabia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 123 Saudi Arabia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 124 Saudi Arabia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
TABLE 125 UAE Herpes Simplex Virus Treatment Market, By Treatment, 2018 - 2030 (USD Million)
TABLE 126 UAE Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
TABLE 127 UAE Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
TABLE 128 UAE Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
TABLE 129 UAE Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Herpes Simplex Virus Treatment Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Market Penetration & Growth Prospect Mapping
FIG. 15 Herpes Simplex Virus Treatment Market: TreatmentMovement Analysis
FIG. 16 Herpes Simplex Virus-1 (HSV-1)market, 2018 - 2030 (USD Million)
FIG. 17 Herpes simplex virus-2 (HSV-2)market, 2018 - 2030 (USD Million)
FIG. 18 Herpes Simplex Virus Treatment Market: Drug Movement Analysis
FIG. 19 Acyclovir market, 2018 - 2030 (USD Million)
FIG. 20 Valacyclovir market, 2018 - 2030 (USD Million)
FIG. 21 Famciclovir market, 2018 - 2030 (USD Million)
FIG. 22 Others drugs market, 2018 - 2030 (USD Million)
FIG. 23 Herpes Simplex Virus Treatment Market: Vaccine Movement Analysis
FIG. 24 Simplirixmarket, 2018 - 2030 (USD Million)
FIG. 25 Others market, 2018 - 2030 (USD Million)
FIG. 26 Herpes Simplex Virus Treatment Market: Route of Administration Movement Analysis
FIG. 27 Oral market, 2018 - 2030 (USD Million)
FIG. 28 Injectable market, 2018 - 2030 (USD Million)
FIG. 29 Topical market, 2018 - 2030 (USD Million)
FIG. 30 Herpes Simplex Virus Treatment Market: End-use Movement Analysis
FIG. 31 Hospital pharmacy market, 2018 - 2030 (USD Million)
FIG. 32 Retail pharmacy market, 2018 - 2030 (USD Million)
FIG. 33 Online pharmacy market, 2018 - 2030 (USD Million)
FIG. 34 Regional Marketplace: Key Takeaways
FIG. 35 Regional Outlook, 2018 & 2030
FIG. 36 Regional Market Dashboard
FIG. 37 Regional Market Place: Key Takeaways
FIG. 38 North America, SWOT Analysis
FIG. 39 Europe, SWOT Analysis
FIG. 40 Asia Pacific, SWOT Analysis
FIG. 41 Latin America, SWOT Analysis
FIG. 42 MEA, SWOT Analysis
FIG. 43 North America
FIG. 44 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 45 U.S.
FIG. 46 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 47 Canada
FIG. 48 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 49 Europe
FIG. 50 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 51 U.K.
FIG. 52 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 53 Germany
FIG. 54 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 55 France
FIG. 56 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 57 Italy
FIG. 58 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 59 Spain
FIG. 60 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 61 Asia Pacific
FIG. 62 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 63 Japan
FIG. 64 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 65 China
FIG. 66 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 67 India
FIG. 68 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 69 Australia
FIG. 70 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 71 South Korea
FIG. 72 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 73 Latin America
FIG. 74 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 75 Brazil
FIG. 76 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 77 Mexico
FIG. 78 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 79 Argentina
FIG. 80 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 81 MEA
FIG. 82 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 83 South Africa
FIG. 84 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 85 Saudi Arabia
FIG. 86 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 87 UAE
FIG. 88 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 89 Strategy Mapping
FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Herpes Simplex Virus Treatment Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Market Penetration & Growth Prospect Mapping
FIG. 15 Herpes Simplex Virus Treatment Market: TreatmentMovement Analysis
FIG. 16 Herpes Simplex Virus-1 (HSV-1)market, 2018 - 2030 (USD Million)
FIG. 17 Herpes simplex virus-2 (HSV-2)market, 2018 - 2030 (USD Million)
FIG. 18 Herpes Simplex Virus Treatment Market: Drug Movement Analysis
FIG. 19 Acyclovir market, 2018 - 2030 (USD Million)
FIG. 20 Valacyclovir market, 2018 - 2030 (USD Million)
FIG. 21 Famciclovir market, 2018 - 2030 (USD Million)
FIG. 22 Others drugs market, 2018 - 2030 (USD Million)
FIG. 23 Herpes Simplex Virus Treatment Market: Vaccine Movement Analysis
FIG. 24 Simplirixmarket, 2018 - 2030 (USD Million)
FIG. 25 Others market, 2018 - 2030 (USD Million)
FIG. 26 Herpes Simplex Virus Treatment Market: Route of Administration Movement Analysis
FIG. 27 Oral market, 2018 - 2030 (USD Million)
FIG. 28 Injectable market, 2018 - 2030 (USD Million)
FIG. 29 Topical market, 2018 - 2030 (USD Million)
FIG. 30 Herpes Simplex Virus Treatment Market: End-use Movement Analysis
FIG. 31 Hospital pharmacy market, 2018 - 2030 (USD Million)
FIG. 32 Retail pharmacy market, 2018 - 2030 (USD Million)
FIG. 33 Online pharmacy market, 2018 - 2030 (USD Million)
FIG. 34 Regional Marketplace: Key Takeaways
FIG. 35 Regional Outlook, 2018 & 2030
FIG. 36 Regional Market Dashboard
FIG. 37 Regional Market Place: Key Takeaways
FIG. 38 North America, SWOT Analysis
FIG. 39 Europe, SWOT Analysis
FIG. 40 Asia Pacific, SWOT Analysis
FIG. 41 Latin America, SWOT Analysis
FIG. 42 MEA, SWOT Analysis
FIG. 43 North America
FIG. 44 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 45 U.S.
FIG. 46 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 47 Canada
FIG. 48 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 49 Europe
FIG. 50 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 51 U.K.
FIG. 52 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 53 Germany
FIG. 54 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 55 France
FIG. 56 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 57 Italy
FIG. 58 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 59 Spain
FIG. 60 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 61 Asia Pacific
FIG. 62 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 63 Japan
FIG. 64 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 65 China
FIG. 66 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 67 India
FIG. 68 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 69 Australia
FIG. 70 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 71 South Korea
FIG. 72 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 73 Latin America
FIG. 74 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 75 Brazil
FIG. 76 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 77 Mexico
FIG. 78 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 79 Argentina
FIG. 80 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 81 MEA
FIG. 82 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 83 South Africa
FIG. 84 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 85 Saudi Arabia
FIG. 86 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 87 UAE
FIG. 88 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 89 Strategy Mapping
